Answers are grounded in this paper and cite their sources.
Finds COVID-19 increases breast cancer aggressiveness, suggesting a link with neutrophil traps.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related critical illness, i.e., severe form of coronavirus disease 2019 (COVID-19), is associated with a hyperinflammatory state. In COVID-19 disease, several components of the body, including the complement system, different cells such as endothelial cells, platelets, monocytes, and neutrophils, and various pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor α, can contribute to a state of coagulopathy, and ultimately, all these factors cause extensive tissue damage. This pathological process may contribute to increased aggressiveness in cancer cells or to the reawakening of dormant cancer cells. Studies have documented an increase in the incidence of aggressive breast cancer, such as triple-negative breast cancer, tumors with overexpression of human epidermal growth factor receptor 2 (HER2), and lymph node involvement during the COVID-19 pandemic. One etiological mechanism is perhaps the activation of neutrophils and the formation of neutrophil extracellular traps, which are thought to be linked to both severe COVID-19 disease and aggressive tumors.
No takes yet. Share an insight, caveat, or question.
Ray et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: